Study finds altered gut microbiota in infants with food allergy; oral therapy to replenish bacteria prevented food allergy and suppressed established disease in mice.
Every three minutes, a food-related allergic reaction sends someone to the emergency room in the U.S. Currently, the only way to prevent a reaction is for people with food allergies to completely avoid the food to which they are allergic. Researchers are actively seeking new treatments to prevent or reverse food allergies in patients. Recent insights about the microbiome — the complex ecosystem of microorganisms that live in the gut and other body sites — have suggested that an altered gut microbiome may play a pivotal role in the development of food allergies. A new study, led by investigators from Brigham and Women’s Hospital and Boston Children’s Hospital, identifies the species of bacteria in the human infant gut that protect against food allergies, finding changes associated with the development of food allergies and an altered immune response. In preclinical studies in a mouse model of food allergy, the team found that giving an enriched oral formulation of five or six species of bacteria found in the human gut protected against food allergies and reversed established disease by reinforcing tolerance of food allergens. The team’s results are published in Nature Medicine.
“This represents a sea change in our approach to therapeutics for food allergies,” said co-senior author Lynn Bry, MD, PhD, director of the Massachusetts Host-Microbiome Center at the Brigham. “We’ve identified the microbes that are associated with protection and ones that are associated with food allergies in patients. If we administer defined consortia representing the protective microbes as a therapeutic, not only can we prevent food allergies from happening, but we can reverse existing food allergies in preclinical models. With these microbes, we are resetting the immune system.”
The research team conducted studies in both humans and preclinical models to understand the key bacterial species involved in food allergies. The team repeatedly collected fecal samples every four to six months from 56 infants who developed food allergies, finding many differences when comparing their microbiota to 98 infants who did not develop food allergies. Fecal microbiota samples from infants with or without food allergies were transplanted into mice who were sensitized to eggs. Mice who received microbiota from healthy controls were more protected against egg allergy than those who received microbiota from the infants with food allergies.
Using computational approaches, researchers analyzed differences in the microbes of children with food allergies compared to those without in order to identify microbes associated with protection or food allergies in patients. The team tested to see if orally administering protective microbes to mice could prevent the development of food allergies. They developed two consortia of bacteria that were protective. Two separate consortia of five or six species of bacteria derived from the human gut that belong to species within the Clostridiales or the Bacteroidetes could suppress food allergies in the mouse model, fully protecting the mice and keeping them resistant to egg allergy. Giving other species of bacteria did not provide protection.
“It’s very complicated to look at all of the microbes in the gut and make sense of what they may be doing in food allergy, but by using computational approaches, we were able to narrow in on a specific group of microbes that are associated with a protective effect,” said co-first author Georg Gerber, MD, PhD, MPH, co-director of the Massachusetts Host-Microbiome Center and chief of the Division of Computational Pathology in the Department of Pathology at the Brigham. “Being able to drill down from hundreds of microbial species to just five or six or so has implications for therapeutics and, from a basic science perspective, means that we can start to figure out how these specific bacteria are conferring protection.”
To understand how the bacteria species might be influencing food allergy susceptibility, the team also looked at immunological changes, both in the human infants and in mice. They found that the Clostridiales and Bacteroidetes consortia targeted two important immunological pathways and stimulated specific regulatory T cells, a class of cells that modulate the immune system, changing their profile to promote tolerant responses instead of allergic responses. These effects were found both in the pre-clinical models and also found to occur in human infants.
The new approach represents a marked contrast to oral immunotherapy, a strategy that aims to increase the threshold for triggering an allergic reaction by giving an individual small but increasing amounts of a food allergen. Unlike this approach, the bacteriotherapy changes the immune system’s wiring in an allergen-independent fashion, with potential to broadly treat food allergies rather than desensitizing an individual to a specific allergen.
“When you can get down to a mechanistic understanding of what microbes, microbial products, and targets on the patient side are involved, not only are you doing great science, but it also opens up the opportunity for finding a better therapeutic and a better diagnostic approach to disease. With food allergies, this has given us a credible therapeutic that we can now take forward for patient care,” said Bry.
Learn more: New Therapy Targets Gut Bacteria to Prevent and Reverse Food Allergies
The Latest on: Gut microbiome
[google_news title=”” keyword=”gut microbiome” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gut microbiome
- Gut microbes that get you drunk and damage your liver − how the microbiome can create a microbreweryon April 26, 2024 at 12:05 pm
People with this syndrome carry microbes in their intestines that produce abnormally high levels of alcohol when breaking down sugars and carbohydrates. Though it’s a rare condition, a woman was ...
- AI helps researchers uncover gut-brain interactions in Alzheimer'son April 26, 2024 at 10:00 am
AI technology reveals more information about the gut-brain health link in Alzheimer's, suggesting new pathways for research around treatments.
- 5 Key Identifiers of a Happy, Healthy, Inflammation-Free Gut Microbiomeon April 26, 2024 at 7:52 am
Certain yoga poses help stimulate digestion through gentle massage, and diaphragmatic breathing during yoga can reduce stress and stimulate the digestive system." ...
- Why a balanced scalp microbiome is key to getting healthy, thick hairon April 26, 2024 at 6:58 am
If you’re already taking a pre- or probiotic, then you’ll be aware of the positive impact of balancing your biome. Now, our relatively recent preoccupation with gut health and how bacteria can ...
- More Data Finds Long-Term Exposure to Toxic Pesticides Alters Human Gut Microbiome and Metabolismon April 25, 2024 at 9:01 pm
Researchers build on research when assessing the relationship between long-term exposure to organophosphorus pesticides and the human gut microbiome.
- Diet's impact on gut bacteria offers new clues in Parkinson's disease managementon April 25, 2024 at 6:35 pm
Researchers find that diet significantly influences the gut microbiome in Parkinson's disease patients, potentially affecting disease progression and symptoms.
- Vitamin D may balance gut microbiome to give cancer immunotherapy a booston April 25, 2024 at 12:30 pm
A new study in mice found that dietary vitamin D plays a role in balancing the gut microbiome and improving the way cancer immunotherapy works to fight tumors.
- Common Sweetener May Damage Gut and Cause Diarrheaon April 24, 2024 at 10:00 am
The synthetic additives could also be transforming otherwise healthy gut bacteria into dangerous agents of disease.
- Are Direct-to-Consumer Microbiome Tests Clinically Useful?on April 24, 2024 at 6:37 am
Some companies claim they can identify and treat gastrointestinal problems with proprietary technology and products — experts disagree.
- Gut Microbiome Linked to Alzheimer's Disease, Scientists Sayon April 23, 2024 at 3:23 am
The findings could lead to the development of new therapeutic interventions or drugs to prevent Alzheimer's disease.
via Bing News